Found: 15
Select item for more details and to access through your institution.
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01227-5
- By:
- Publication type:
- Article
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01227-5
- By:
- Publication type:
- Article
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies.
- Published in:
- Acta Neuropsychiatrica, 2017, v. 29, n. 5, p. 278, doi. 10.1017/neu.2016.57
- By:
- Publication type:
- Article
Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
- Published in:
- International Journal of Geriatric Psychiatry, 2008, v. 23, n. 9, p. 979, doi. 10.1002/gps.1979
- By:
- Publication type:
- Article
Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 2, p. 339, doi. 10.1007/s40120-023-00575-5
- By:
- Publication type:
- Article
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial.
- Published in:
- Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01688-w
- By:
- Publication type:
- Article
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01521-w
- By:
- Publication type:
- Article
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-021-01376-7
- By:
- Publication type:
- Article
A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder.
- Published in:
- Acta Neuropsychiatrica, 2019, v. 31, n. 1, p. 27, doi. 10.1017/neu.2018.23
- By:
- Publication type:
- Article
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
- Published in:
- Cephalalgia, 2023, v. 43, n. 5, p. 1, doi. 10.1177/03331024231170807
- By:
- Publication type:
- Article
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 4, p. 1089, doi. 10.1111/ene.15670
- By:
- Publication type:
- Article